Find out how stereotactic body radiation therapy (SBRT) with CyberKnife® can benefit prostate cancer patients. Below are some advantages from Philadelphia CyberKnife radiation oncologist Dr. Rachelle Lanciano.
What sets CyberKnife apart from other treatment options?
CyberKnife offers patients a noninvasive treatment option that doesn’t impede on their lifestyle. CyberKnife can treat prostate cancer patients in five or fewer sessions, a much shorter time period than conventional forms of treatment, and patients can return to their normal routines immediately following each session. The accuracy of treatment can also reduce side effects associated with other forms of treatment for prostate cancer.
How is SBRT with CyberKnife different from conventional radiation therapy?
CyberKnife has the ability to directly target the prostate while compensating for normal patient movements, which minimizes radiation exposure to surrounding healthy tissue. Treatment time is also significantly shorter given traditional radiation therapy can last up to seven to eight weeks. CyberKnife treatment for prostate cancer is completed within five sessions lasting one to two weeks.
Is CyberKnife treatment covered by insurance?
We accept most insurance coverage as well as Medicare.
To find out whether you may be a candidate for CyberKnife treatment, request more information.